Putting chirality to work: the strategy of chiral switches

Arzneimittelforschung

Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,401 · see citing works

Goodman and Gilman's the Pharmacological Basis of Therapeutics

Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,796 · see citing works

Stereochemistry of organic compounds

Peakman, T. M. (1995) · Geochimica et Cosmochimica Acta · doi:10.1016/0016-7037(95)90151-5 · Cited by 2,947 · see citing works

Stereochemistry of Organic Compounds

Wilen, S. H., Mander, L. N., & Eliel, E. L. (1962) · Medical Entomology and Zoology · Cited by 2,599 · see citing works

Goodman and Gilman's the Pharmacological Basis of Therapeutics

Coon, J. T. (2002) · Focus on Alternative and Complementary Therapies · doi:10.1111/j.2042-7166.2002.tb05480.x · Cited by 1,750 · see citing works

Valvular heart disease associated with fenfluramine-phentermine

Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., & Schaff, H. V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370901 · Cited by 1,632 · see citing works

Appetite-suppressant drugs and the risk of primary pulmonary hypertension

Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350901 · Cited by 1,162 · see citing works

Basic terminology of stereochemistry (IUPAC Recommendations 1996)

Moss, G. P. (1996) · Pure and Applied Chemistry · doi:10.1351/pac199668122193 · Cited by 884 · see citing works

Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology

Ari�ns, E. J. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00541922 · Cited by 614 · see citing works

FDA'S policy statement for the development of new stereoisomeric drugs

(1992) · Chirality · doi:10.1002/chir.530040513 · Cited by 582 · see citing works

Appetite-suppressant drugs and the risk of primary pulmonary hypertension

Abenhaim, L. (1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)89579-7 · Cited by 562 · see citing works

A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine

Wong, D. T., Horng, J. S., Bymaster, F. P., Hauser, K. L., & Molloy, B. B. (1974) · Life Sciences · doi:10.1016/0024-3205(74)90345-2 · Cited by 480 · see citing works

The metabolic chiral inversion of 2-arylpropionic acids—a novel route with pharmacological consequences

Hutt, A. J., & Caldwell, J. (1983) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1983.tb02874.x · Cited by 395 · see citing works

Chiral separation techniques : a practical approach

Subramanian, G. (2001) · Cited by 344 · see citing works

The total synthesis of strychnine

Woodward, R. B., Cava, M. P., Ollis, W. D., Hunger, A., Daeniker, H. U., & Schenker, K. (1963) · Tetrahedron · doi:10.1016/s0040-4020(01)98529-1 · Cited by 259 · see citing works

Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide

Eriksson, T., Bjöurkman, S., Roth, B., Fyge, Å., & Höuglund, P. (1995) · Chirality · doi:10.1002/chir.530070109 · Cited by 252 · see citing works

Chromatographische Racemattrennung

Blaschke, G. (1980) · Angewandte Chemie · doi:10.1002/ange.19800920105 · Cited by 224 · see citing works

A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination

Weintraub, M. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.144.6.1143 · Cited by 217 · see citing works

Omeprazole: The first proton pump inhibitor

Lindberg, P., Brändström, A., Wallmark, B., Mattsson, H., Rikner, L., & Hoffmann, K. (1990) · Medicinal Research Reviews · doi:10.1002/med.2610100102 · Cited by 212 · see citing works

Toxicity and Teratogenicity of Optical Isomers of Thalidomide

Fabro, S. E., Smith, R. L., & Williams, R. T. (1967) · Nature · doi:10.1038/215296a0 · Cited by 200 · see citing works

Introduction

WEINTRAUB, M. I. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.68 · Cited by 171 · see citing works

The absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor

Robertson, D. W., Krushinski, J. H., Fuller, R. W., & Leander, J. D. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00402a027 · Cited by 163 · see citing works

Dexanabinol (HU-211) in the treatment of severe closed head injury: A randomized, placebo-controlled, phase II clinical trial*

Knoller, N., Levi, L., Shoshan, I., Reichenthal, E., Razon, N., Rappaport, Z. H., & Biegon, A. R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200203000-00009 · Cited by 161 · see citing works

Long-term weight control study: Conclusions

WEINTRAUB, M. I. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.76 · Cited by 161 · see citing works

Chiral switches

Tucker, G. T. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02047-x · Cited by 147 · see citing works

Chiral Inversion and Hydrolysis of Thalidomide: Mechanisms and Catalysis by Bases and Serum Albumin, and Chiral Stability of Teratogenic Metabolites

Reist, M., Carrupt, P., Francotte, E. R., & Testa, B. (1998) · Chemical Research in Toxicology · doi:10.1021/tx9801817 · Cited by 145 · see citing works

Cardiac and CNS Toxicity of Levobupivacaine

Gristwood, R. W. (2002) · Drug Safety · doi:10.2165/00002018-200225030-00002 · Cited by 135 · see citing works

Clinical Pharmacokinetics of Dexketoprofen

Barbanoj, M. J., Antonijoan, R. M., & Gich, I. J. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140040-00002 · Cited by 133 · see citing works

Intellectual property and chirality of drugs

Agranat, I., & Caner, H. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01363-x · Cited by 131 · see citing works

Aminorex to Fen/Phen

Fishman, A. P. (1999) · Circulation · doi:10.1161/01.cir.99.1.156 · Cited by 129 · see citing works

Esomeprazole

Spencer, C. M., & Faulds, D. M. (2000) · Drugs · doi:10.2165/00003495-200060020-00006 · Cited by 127 · see citing works

Chirality and the biological activity of drugs

Crossley, R. J. (1995) · Cited by 119 · see citing works

Stereochemical aspects of drug action and disposition

Eichelbaum, M. F., & Gross, A. S. (2003) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · doi:10.1016/s0065-2490(96)80003-7 · Cited by 107 · see citing works

Molecular Chirality

Mislow, K. (1999) · Topics in stereochemistry · doi:10.1002/9780470147313.ch1 · Cited by 102 · see citing works

The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer.

Liu, S., Kulp, S. K., Sugimoto, Y., Jiang, J., Chang, H.-L., Dowd, M. K., Wan, P. J., & Lin, Y. C. (2002) · PubMed · Cited by 96 · see citing works

X-ray crystallography and drug action

Testa, B. (1985) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(85)90017-3 · Cited by 89 · see citing works

CHIRAL CHEMISTRY

STINSON, S. C. (2001) · Chemical & Engineering News · doi:10.1021/cen-v079n020.p045 · Cited by 89 · see citing works

Recent developments in structure–activity relationships for steroid modulators of GABAA receptors

Covey, D. F., Evers, A. S., Mennerick, S. J., Zorumski, C. F., & Purdy, R. H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00126-6 · Cited by 84 · see citing works

Levobupivacaine: a new safer long acting local anaesthetic agent

Gristwood, R. W., & Greaves, J. L. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.6.861 · Cited by 80 · see citing works

The new ambidextrous universe : symmetry and asymmetry from mirror reflections to superstrings

Gardner, M. (1990) · CERN Document Server (European Organization for Nuclear Research) · Cited by 68 · see citing works

Comparison of the effects of levocetirizine and loratadine on histamine‐induced wheal, flare, and itch in human skin

Clough, G., Boutsiouki, P., & Church, M. K. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.00204.x · Cited by 67 · see citing works

Stereoselectivity of drug action

Triggle, D. J. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01010-6 · Cited by 63 · see citing works

Resolution of the enantiomers of omeprazole and some of its analogues by liquid chromatography on a trisphenylcarbamoylcellulose-based stationary phase

Erlandsson, P. G., Isaksson, R., Lorentzon, P., & Lindberg, P. (1990) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)83781-0 · Cited by 61 · see citing works

CHIRAL ROUNDUP

ROUCHI, A. M. (2002) · Chemical & Engineering News · doi:10.1021/cen-v080n023.p043 · Cited by 59 · see citing works

European patent convention

Singer, R., Singer, M., & Lunzer, R. (1995) · Cited by 58 · see citing works

The painful reality

Renfrey, S., Downton, C., & Featherstone, J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1038 · Cited by 44 · see citing works

Acid activation of (H + –K + )-ATPase inhibiting 2-(2-pyridylmethyl-sulphinyl)benzimidazoles: isolation and characterization of the thiophilic ‘active principle’ and its reactions

Figala, V., Klemm, K., Kohl, B., Krüger, U., Rainer, G., Schaefer, H. E., Senn‐Bilfinger, J., & Sturm, E. (1986) · Journal of the Chemical Society Chemical Communications · doi:10.1039/c39860000125 · Cited by 43 · see citing works

On the Botanical Distribution of Chiral Forms of Gossypol

Jaroszewski, J. W., Strøm‐Hansen, T., Hansen, S. H., Thastrup, M., & Kofod, H. (1992) · Planta Medica · doi:10.1055/s-2006-961512 · Cited by 42 · see citing works

Esomeprazole for Acid Peptic Disorders

Kale-Pradhan, P. B., Landry, H. K., & Sypula, W. T. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a104 · Cited by 42 · see citing works

Stereochemical origin of some clinically significant drug safety concerns: lessons for future drug development.

Shah, R. R., Midgley, J., & Branch, S. K. (1999) · PubMed · Cited by 42 · see citing works

Pharmacodynamics, pharmacokinetics and toxicity of ibuprofen enantiomers

Mayer, J. M., & Testa, B. (1997) · Drugs of the Future · doi:10.1358/dof.1997.022.12.711853 · Cited by 39 · see citing works

Structural proteomics

Renfrey, S., & Featherstone, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd766 · Cited by 39 · see citing works

Two of a Kind

Wohlrab, J. L., & Anderson, E. (2002) · CHEST Journal · doi:10.1378/chest.122.2.736 · Cited by 37 · see citing works

Development of Stereoisomers (Chiral) Drugs: A Brief Review Of Scientific and Regulatory Considerations

Daniels, J. M., Nestmann, E. R., & Kerr, A. (1997) · Drug Information Journal · doi:10.1177/009286159703100303 · Cited by 37 · see citing works

FDA policy and regulation of stereoisomers: paradigm shift and the future of safer, more effective drugs.

Strong, M. J. (1999) · PubMed · Cited by 36 · see citing works

Electronic "Orange Book"

Nightingale, S. L. (1999) · JAMA · doi:10.1001/jama.281.17.1580-jfd90003-2-1 · Cited by 35 · see citing works

Patents for Chemicals, Pharmaceuticals, and Biotechnology

Grubb, P. W., Thomsen, P. R., Hoxie, T., & Wright, G. (2016) · doi:10.1093/oso/9780199684731.001.0001 · Cited by 29 · see citing works

Levofloxacin

Norrby, S. R. (1999) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.1.109 · Cited by 27 · see citing works

International Regulation of Chiral Drugs

Branch, S. K. (2000) · doi:10.1002/3527600361.ch13 · Cited by 26 · see citing works

Enantiomeric antidepressant drugs should be considered on individual merit

Baumann, P., & Eap, C. B. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.336 · Cited by 26 · see citing works

Prospects for Pharmacological Male Contraception

Matlin, S. A. (1994) · Drugs · doi:10.2165/00003495-199448060-00002 · Cited by 20 · see citing works

Development of a melatonin-based formulation for the treatment of insomnia in the elderly

Zisapel, N. (2000) · Drug Development Research · doi:10.1002/1098-2299(200007/08)50:3/4 · Cited by 16 · see citing works

Levalbuterol hydrochloride

Handley, D. A., Morley, J. E., & Vaickus, L. J. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.12.2027 · Cited by 15 · see citing works

Esomeprazole Magnesium

Graul, A., Castaner, R., & Castañer, J. (1999) · Drugs of the Future · doi:10.1358/dof.1999.024.11.559951 · Cited by 13 · see citing works

Bay-12-9566

Sorbera, L. A., Graul, A., Silvestre, J. S., & Castañer, J. (1999) · Drugs of the Future · doi:10.1358/dof.1999.024.01.483363 · Cited by 10 · see citing works

Synthesis of ent -19-nortestosterone from its naturally occurring antipode

Teerhuis, N. M., Huisman, I. A. M., & Groen, M. B. (2001) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)00296-9 · Cited by 9 · see citing works

Effect of Gossypol on Cultured TM3 Leydig and TM4 Sertoli Cells: 31P and 23Na NMR Study

Hansen, L. L., & Jaroszewski, J. W. (1996) · NMR in Biomedicine · doi:10.1002/(sici)1099-1492(199604)9:2 · Cited by 9 · see citing works

Patents for Inventions

Greener, F. W. G. (1956) · Physics Bulletin · doi:10.1088/0031-9112/7/1/002 · Cited by 9 · see citing works

Stereochemistry: handling interactions

Lloyd, A. W. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01017-9 · Cited by 4 · see citing works

Nova acquires Huntsman's styrenics business

ROGERS, R. S. (1998) · Chemical & Engineering News · doi:10.1021/cen-v076n030.p011a · Cited by 4 · see citing works

IN THE MATTER OF I. G. FARBENINDUSTRIE A. G.'S PATENTS

(1930) · Reports of Patent Design and Trade Mark Cases · doi:10.1093/rpc/47.9.289 · Cited by 4 · see citing works

An introduction to the ?enantiomer debate?

Caldwell, J., & Leonard, B. E. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.340 · Cited by 3 · see citing works

Intellectual Property

Matsushita, M., Schoenbaum, T. J., Mavroidis, P. C., & Hahn, M. (2015) · Oxford University Press eBooks · doi:10.1093/law/9780199571857.003.0017 · Cited by 3 · see citing works

Patent and trademark laws

Samuels, J. M. (1983) · Bureau of National Affairs eBooks · Cited by 2 · see citing works

1.3 Organische Analyse

(1982) · Fresenius Zeitschrift für Analytische Chemie · doi:10.1007/bf00484049 · Cited by 1 · see citing works

EDITORIA

Wilson, A. (1999) · Canadian Theatre Review · doi:10.3138/ctr.98.fm · Cited by 1 · see citing works

Untitled work

(2000) · doi:10.1002/(sici)1520-636x(2000)12:3

Analysis of US FDA-Approved Drugs Containing Sulfur Atoms

Scott, K. A., & Njardarson, J. T. (2018) · Topics in Current Chemistry · doi:10.1007/s41061-018-0184-5 · Cited by 1,055 · see citing works

The Methylation Effect in Medicinal Chemistry

Barreiro, E. J., Kümmerle, A. E., & Fraga, C. A. M. (2011) · Chemical Reviews · doi:10.1021/cr200060g · Cited by 1,024 · see citing works

Assessing Atropisomer Axial Chirality in Drug Discovery and Development

LaPlante, S. R., Fader, L. D., Fandrick, K. R., Fandrick, D. R., Hucke, O., Kemper, R., Miller, S. P. F., & Edwards, P. J. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200584g · Cited by 879 · see citing works

The Challenge of Atropisomerism in Drug Discovery

Clayden, J., Moran, W. J., Edwards, P. J., & LaPlante, S. R. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901719 · Cited by 790 · see citing works

The Significance of Chirality in Drug Design and Development

Brooks, W. H., Guida, W. C., & Daniel, K. G. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795165098 · Cited by 697 · see citing works

Chiral Toxicology: It's the Same Thing…Only Different

Smith, S. W. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp097 · Cited by 606 · see citing works

Deuterium in drug discovery: progress, opportunities and challenges

Martino, R. M. C. D., Maxwell, B. D., & Pirali, T. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00703-8 · Cited by 552 · see citing works

Revealing Atropisomer Axial Chirality in Drug Discovery

LaPlante, S. R., Edwards, P. J., Fader, L. D., Jakalian, A., & Hucke, O. (2011) · ChemMedChem · doi:10.1002/cmdc.201000485 · Cited by 543 · see citing works

The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds

Calcaterra, A., & D’Acquarica, I. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.07.008 · Cited by 489 · see citing works

Pharmacologically active compounds in the environment and their chirality

Kasprzyk‐Hordern, B. (2010) · Chemical Society Reviews · doi:10.1039/c000408c · Cited by 460 · see citing works

Baeyer−Villiger Monooxygenases: More Than Just Green Chemistry

Leisch, H. G., Morley, K. L., & Lau, P. C. K. (2011) · Chemical Reviews · doi:10.1021/cr1003437 · Cited by 445 · see citing works

Structure Control of Polysaccharide Derivatives for Efficient Separation of Enantiomers by Chromatography

Ikai, T., & Okamoto, Y. (2009) · Chemical Reviews · doi:10.1021/cr8005558 · Cited by 433 · see citing works

Three-Dimensional Chiral Plasmonic Oligomers

Hentschel, M., Schäferling, M., Weiss, T., Kuball, H., Liu, N., & Giessen, H. W. (2012) · Nano Letters · doi:10.1021/nl300769x · Cited by 406 · see citing works

Trends in the development of chiral drugs

Caner, H., Finkin-Groner, E., Levy, L., & Agranat, I. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02904-0 · Cited by 399 · see citing works

From individual to collective chirality in metal nanoparticles

Guerrero‐Martínez, A., Alonso‐Gómez, J. L., Auguié, B., Cid, M. M., & Liz‐Marzán, L. M. (2011) · Nano Today · doi:10.1016/j.nantod.2011.06.003 · Cited by 309 · see citing works

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes

Sanganyado, E., Lu, Z., Fu, Q., Schlenk, D., & Gan, J. J. (2017) · Water Research · doi:10.1016/j.watres.2017.08.003 · Cited by 295 · see citing works

Industrial Applications of the Diels–Alder Reaction

Funel, J., & Abele, S. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201201636 · Cited by 292 · see citing works

Chirality of New Drug Approvals (2013–2022): Trends and Perspectives

McVicker, R. U., & O’Boyle, N. M. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02239 · Cited by 261 · see citing works

Escitalopram versus citalopram: the surprising role of the R-enantiomer

S�nchez, C., B�ges�, K. P., Ebert, B., Reines, E. H., & Bræstrup, C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1865-z · Cited by 248 · see citing works

Enantioseparations by using capillary electrophoretic techniques

Chankvetadze, B. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.08.008 · Cited by 238 · see citing works

Enantioselective Synthesis of 3-Arylquinazolin-4(3 H )-ones via Peptide-Catalyzed Atroposelective Bromination

Diener, M. E., Metrano, A. J., Kusano, S., & Miller, S. J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b07726 · Cited by 224 · see citing works

Chiral Protein Supraparticles for Tumor Suppression and Synergistic Immunotherapy: An Enabling Strategy for Bioactive Supramolecular Chirality Construction

Yan, J., Yao, Y., Yan, S., Gao, R., Lu, W., & He, W. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01757 · Cited by 212 · see citing works

Integrated Molar Chiral Sensing Based on High-Q Metasurface

Chen, Y., Zhao, C., Zhang, Y., & Qiu, C. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c03506 · Cited by 199 · see citing works

Supercritical fluid chromatography for the enantioseparation of pharmaceuticals

Klerck, K. D., Mangelings, D., & Heyden, Y. V. (2012) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2012.01.021 · Cited by 195 · see citing works

Chiral Supraparticles for Controllable Nanomedicine

Yeom, J., Guimarães, P. P. G., Ahn, H. M., Jung, B., Hu, Q., McHugh, K. J., Mitchell, M. J., Yun, C., Langer, R., & Jaklenec, A. (2019) · Advanced Materials · doi:10.1002/adma.201903878 · Cited by 191 · see citing works

Chiral metamaterials: enhancement and control of optical activity and circular dichroism

Oh, S. S., & Hess, O. G. (2015) · Nano Convergence · doi:10.1186/s40580-015-0058-2 · Cited by 189 · see citing works

A review of drug isomerism and its significance

Chhabra, N., Aseri, M., & Padmanabhan, D. (2013) · International Journal of Applied and Basic Medical Research · doi:10.4103/2229-516x.112233 · Cited by 186 · see citing works

Atropisomerie als Herausforderung in der Medikamentenentwicklung

Clayden, J., Moran, W. J., Edwards, P. J., & LaPlante, S. R. (2009) · Angewandte Chemie · doi:10.1002/ange.200901719 · Cited by 185 · see citing works

Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs

Wang, Y., Dix, M. M., Bianco, G., Remsberg, J. R., Lee, H.-Y., Kalocsay, M., Gygi, S. P., Forli, S., Vite, G., Lawrence, R. M., et al. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0351-5 · Cited by 179 · see citing works

Catalytic Enantioselective Synthesis and Switchable Chiroptical Property of Inherently Chiral Macrocycles

Tong, S., Li, J., Liang, D., Zhang, Y.-E., Feng, Q.-Y., Zhang, X., Zhu, J., & Wang, M. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c05369 · Cited by 168 · see citing works

Mechanistic and functional differentiation of tapentadol and tramadol

Raffa, R. B., Buschmann, H., Christoph, T., Eichenbaum, G. M., Englberger, W., Flores, C. M., Hertrampf, T., Kögel, B. Y., Schiene, K., Straßburger, W., et al. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.696097 · Cited by 165 · see citing works

Chirality-assisted lateral momentum transfer for bidirectional enantioselective separation

Shi, Y., Zhu, T., Zhang, T., Mazzulla, A., Tsai, D. P., Ding, W., Liu, A. Q., Cipparrone, G., Sáenz, J. J., & Qiu, C. (2020) · Light Science & Applications · doi:10.1038/s41377-020-0293-0 · Cited by 159 · see citing works

Circular Dichroism Studies on Plasmonic Nanostructures

Wang, X., & Tang, Z. (2016) · Small · doi:10.1002/smll.201601115 · Cited by 154 · see citing works

Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton’s Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers

Watterson, S. H., Lucca, G. V. D., Shi, Q., Langevine, C. M., Liu, Q., Batt, D. G., Bertrand, M. B., Gong, H., Dai, J., Yip, S. H., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01088 · Cited by 153 · see citing works

Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). I. Drugs in preclinical and early clinical development

Bialer, M., Johannessen, S. I., Koepp, M. J., Levy, R. H., Perucca, E., Perucca, P., Tomson, T., & White, H. S. (2020) · Epilepsia · doi:10.1111/epi.16725 · Cited by 149 · see citing works

A Novel Whole-Cell Biocatalyst with NAD+ Regeneration for Production of Chiral Chemicals

Xiao, Z., Lv, C., Gao, C., Qin, J., Ma, C., Liu, Z., Liu, P., Li, L., & Xu, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008860 · Cited by 140 · see citing works

Chiral Switch: Between Therapeutical Benefit and Marketing Strategy

Hancu, G., & Modroiu, A. (2022) · Pharmaceuticals · doi:10.3390/ph15020240 · Cited by 140 · see citing works

Recent Advances in Ultrathin Chiral Metasurfaces by Twisted Stacking

Han, Z., Wang, F., Sun, J., Wang, X., & Tang, Z. (2022) · Advanced Materials · doi:10.1002/adma.202206141 · Cited by 136 · see citing works

Stereodivergent Synthesis of Enantioenriched 2,3-Disubstituted Dihydrobenzofurans via a One-Pot C–H Functionalization/Oxa-Michael Addition Cascade

Zhu, D., Liu, J., & Xu, M. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c03498 · Cited by 129 · see citing works

Light-empowered contra-thermodynamic stereochemical editing

Wang, P., Xiao, W., & Chen, J. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00441-2 · Cited by 127 · see citing works

Chiral Separations

Stalcup, A. M. (2010) · Annual Review of Analytical Chemistry · doi:10.1146/annurev.anchem.111808.073635 · Cited by 122 · see citing works

Enantioselective Synthesis of Hemiaminals via Pd-Catalyzed C–N Coupling with Chiral Bisphosphine Mono-oxides

Li, H., Belyk, K. M., Yin, J., Chen, Q., Hyde, A. M., Ji, Y., Oliver, S. F., Tudge, M. T., Campeau, L., & Campos, K. R. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b05934 · Cited by 121 · see citing works

Origin of Stereodivergence in Cooperative Asymmetric Catalysis with Simultaneous Involvement of Two Chiral Catalysts

Bhaskararao, B., & Sunoj, R. B. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b05902 · Cited by 120 · see citing works

Continuous flow asymmetric synthesis of chiral active pharmaceutical ingredients and their advanced intermediates

Ötvös, S. B., & Kappe, C. O. (2021) · Green Chemistry · doi:10.1039/d1gc01615f · Cited by 119 · see citing works

Enantioselective Degradation and Ecotoxicity of the Chiral Herbicide Diclofop in Three Freshwater Alga Cultures

Cai, X., Liu, W., & Sheng, G. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0728855 · Cited by 118 · see citing works

Practical access to axially chiral sulfonamides and biaryl amino phenols via organocatalytic atroposelective N-alkylation

Lu, S., Ng, S. V. H., Lovato, K., Ong, J., Poh, S. B., Ng, X. Q., Kürti, L., & Zhao, Y. (2019) · Nature Communications · doi:10.1038/s41467-019-10940-4 · Cited by 114 · see citing works

Use of a Robust Dehydrogenase from an Archael Hyperthermophile in Asymmetric Catalysis−Dynamic Reductive Kinetic Resolution Entry into ( S )-Profens

Friest, J. A., Maezato, Y., Broussy, S., Blum, P., & Berkowitz, D. B. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910778p · Cited by 106 · see citing works

Advances in Asymmetric Di‐and Trifluoromethylthiolation, and Di‐ and Trifluoromethoxylation Reactions

Hardy, M. A., Chachignon, H., & Cahard, D. (2019) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.201900004 · Cited by 105 · see citing works

Some thoughts about enantioseparations in capillary electrophoresis

Fanali, S., & Chankvetadze, B. (2019) · Electrophoresis · doi:10.1002/elps.201900144 · Cited by 105 · see citing works

Enantiomeric separation and determination of absolute stereochemistry of asymmetric molecules in drug discovery—Building chiral technology toolboxes

McConnell, O. J., Bach, A., Balibar, C. J., Byrne, N., Cai, Y., Carter, G., Chlenov, M. A., Di, L., Fan, K. Y., Goljer, I., et al. (2007) · Chirality · doi:10.1002/chir.20399 · Cited by 104 · see citing works

Design, Synthesis, and Biological Evaluation of Novel Deguelin-Based Heat Shock Protein 90 (HSP90) Inhibitors Targeting Proliferation and Angiogenesis

Chang, D.-J., An, H., Kim, K.-S., Kim, H. H., Jung, J., Lee, J. M., Kim, N., Han, Y. T., Yun, H., Lee, S.-J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301488q · Cited by 102 · see citing works

Asymmetric enzymatic oxidoreductions in organic solvents

Klibanov, A. M. (2003) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(03)00074-0 · Cited by 101 · see citing works

Characterization and its Potential Application of Two Esterases Derived from the Arctic Sediment Metagenome

Jeon, J. H., Kim, J.-T., Kang, S. G., Lee, J.-H., & Kim, S. (2008) · Marine Biotechnology · doi:10.1007/s10126-008-9145-2 · Cited by 101 · see citing works

The Thalidomide Disaster, Lessons from the Past

Ridings, J. E. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-131-8_36 · Cited by 100 · see citing works

Novel strong cation-exchange type chiral stationary phase for the enantiomer separation of chiral amines by high-performance liquid chromatography

Hoffmann, C. V., Laemmerhofer, M., & Lindner, W. F. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.05.092 · Cited by 95 · see citing works

Enantioselectivity in the toxicological effects of chiral pesticides: A review

Ji, C., Song, Z., Tian, Z., Feng, Z., Fan, L., Shou, C., & Zhao, M. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159656 · Cited by 93 · see citing works

Enantioselective Synthesis of Inherently Chiral Calix[4]arenes via Palladium-Catalyzed Asymmetric Intramolecular C–H Arylations

Zhang, Y., Xu, M., Si, X., Hou, J., & Cai, Q. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c10606 · Cited by 93 · see citing works

Plasmonic Diastereomers: Adding up Chiral Centers

Hentschel, M., Schäferling, M., Metzger, B., & Giessen, H. W. (2012) · Nano Letters · doi:10.1021/nl3041355 · Cited by 93 · see citing works

Reconfigurable Plasmonic Diastereomers Assembled by DNA Origami

Wang, M., Dong, J., Zhou, C., Xie, H., Ni, W., Wang, S., Jin, H., & Wang, Q. (2019) · ACS Nano · doi:10.1021/acsnano.9b06734 · Cited by 92 · see citing works

Stereoselective Disposition of Proton??Pump Inhibitors

Andersson, T., & Weidolf, L. O. G. (2008) · Clinical Drug Investigation · doi:10.2165/00044011-200828050-00001 · Cited by 90 · see citing works

The predicated demise of racemic new molecular entities is an exaggeration

Agranat, I., Wainschtein, S. R., & Zusman, E. Z. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3657-c1 · Cited by 85 · see citing works

Quo vadis, plasmonic optical tweezers?

Crozier, K. B. (2019) · Light Science & Applications · doi:10.1038/s41377-019-0146-x · Cited by 84 · see citing works

Chirality sorting using two-wave-interference–induced lateral optical force

Chen, H., Liang, C., Liu, S., & Lin, Z. (2016) · Physical Review A · doi:10.1103/physreva.93.053833 · Cited by 83 · see citing works

Biomolecule-mediated chiral nanostructures: a review of chiral mechanism and application

Wen, Y., He, M., Yu, Y., & Wang, J. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2021.102376 · Cited by 81 · see citing works

Synthesis of the optical isomers of a new anticholinergic drug, penehyclidine hydrochloride (8018)

Han, X., Liu, H., Liu, C., Wu, B., Chen, L., Zhong, B., & Liu, K. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.02.071 · Cited by 80 · see citing works

Facing chirality in the 21st century: Approaching the challenges in the pharmaceutical industry

Federsel, H. (2003) · Chirality · doi:10.1002/chir.10274 · Cited by 79 · see citing works

Catalytic Enantioselective Synthesis of Inherently Chiral Molecules: Recent Advances

Tang, M., & Yang, X. (2023) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202300738 · Cited by 78 · see citing works

Highly Enantioselective Synthesis of 2,3-Dihydroquinazolinones through Intramolecular Amidation of Imines

Prakash, M., & Kesavan, V. (2012) · Organic Letters · doi:10.1021/ol300518m · Cited by 78 · see citing works

Chirality of Metal Nanoparticles in Chiral Mesoporous Silica

Xie, J., Duan, Y., & Che, S. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201200588 · Cited by 78 · see citing works

Deracemization of NMPA via Temperature Cycles

Breveglieri, F., Maggioni, G. M., & Mazzotti, M. (2018) · Crystal Growth & Design · doi:10.1021/acs.cgd.7b01746 · Cited by 78 · see citing works

Structural Requirements for Cannabinoid Receptor Probes

Thakur, G. A., Nikas, S. P., Li, C., & Makriyannis, A. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_7 · Cited by 77 · see citing works

Immobilized-type chiral packing materials for HPLC based on polysaccharide derivatives

Ikai, T., Yamamoto, C., Kamigaito, M., & Okamoto, Y. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.04.047 · Cited by 75 · see citing works

Chirality as an Important Factor for the Development of New Antiepileptic Drugs

Abram, M., Jakubiec, M., & Kamiński, K. (2019) · ChemMedChem · doi:10.1002/cmdc.201900367 · Cited by 73 · see citing works

Catalytic Asymmetric Synthesis of Chiral Caged Hydrocarbons as Arenes Bioisosteres

Yang, X.-C., Wang, J., Xiao, Y., & Feng, J. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202505803 · Cited by 73 · see citing works

High-performance liquid chromatography enantioseparation of proton pump inhibitors using the immobilized amylose-based Chiralpak IA chiral stationary phase in normal-phase, polar organic and reversed-phase conditions

Cirilli, R., Ferretti, R., Gallinella, B., Santis, E. D., Zanitti, L., & Torre, F. L. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.11.027 · Cited by 73 · see citing works

Distinguishing and Quantifying Peptides and Proteins Containing d -Amino Acids by Tandem Mass Spectrometry

Adams, C. M., & Zubarev, R. A. (2005) · Analytical Chemistry · doi:10.1021/ac0503963 · Cited by 73 · see citing works

Enzyme‐Modified Particles for Selective Biocatalytic Hydrogenation by Hydrogen‐Driven NADH Recycling

Reeve, H. A., Lauterbach, L., Lenz, O., & Vincent, K. A. (2015) · ChemCatChem · doi:10.1002/cctc.201500766 · Cited by 72 · see citing works

Chirality Remote Control in Nanoporous Materials by Circularly Polarized Light

Kanj, A. B., Bürck, J., Vankova, N., Li, C., Mutruc, D., Chandresh, A., Hecht, S., Heine, T., & Heinke, L. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c01693 · Cited by 71 · see citing works

Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: A 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients

Yevtushenko, V. Y., Belous, A., Yevtushenko, Y. G., Gusinin, S. E., Buzik, O. Z., & Agibalova, T. V. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.11.014 · Cited by 71 · see citing works

Chirality of organophosphorus pesticides: Analysis and toxicity

Nillos, M. G., Gan, J. J., & Schlenk, D. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.11.022 · Cited by 71 · see citing works

The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1)

Courilleau, D., Bouyssou, P., Fischmeister, R., Lezoualc’h, F., & Blondeau, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.107 · Cited by 71 · see citing works

Enantiomeric profiling of a chemically diverse mixture of chiral pharmaceuticals in urban water

Evans, S. I., Bagnall, J. P., & Kasprzyk‐Hordern, B. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2017.06.070 · Cited by 71 · see citing works

Turning chiral peptides into a racemic supraparticle to induce the self-degradation of MDM2

Yang, W., Liu, W., Li, X., Yan, J., & He, W. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.05.009 · Cited by 70 · see citing works

Strategies for discovery and improvement of enzyme function: state of the art and opportunities

Kaul, P., & Asano, Y. (2011) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2011.00280.x · Cited by 68 · see citing works

Synthesis of cationic single-isomer cyclodextrins for the chiral separation of amino acids and anionic pharmaceuticals

Tang, W., & Ng, S. (2007) · Nature Protocols · doi:10.1038/nprot.2007.479 · Cited by 68 · see citing works

P-Stereogenic Phosphines Directed Copper(I)-Catalyzed Enantioselective 1,3-Dipolar Cycloadditions

Gan, Z., Zhi, M., Han, R., Li, E., Duan, Z., & Mathey, F. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b00734 · Cited by 68 · see citing works

Industrielle Anwendungen der Diels‐Alder‐Reaktion

Funel, J., & Abele, S. (2013) · Angewandte Chemie · doi:10.1002/ange.201201636 · Cited by 67 · see citing works

Stereoselective oxidations and reductions catalyzed by nonredox proteins

Dzyuba, S. V., & Klibanov, A. M. (2004) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2004.04.035 · Cited by 67 · see citing works

Amino Acid-Based Fluorescent Chiral Ionic Liquid for Enantiomeric Recognition

Bwambok, D. K., Challa, S. K., Lowry, M., & Warner, I. M. (2010) · Analytical Chemistry · doi:10.1021/ac9027774 · Cited by 66 · see citing works

New Trends in the Quality Control of Enantiomeric Drugs: Quality by Design-Compliant Development of Chiral Capillary Electrophoresis Methods

Orlandini, S., Hancu, G., Szabó, Z., Modroiu, A., Papp, L. A., Gotti, R., & Furlanetto, S. (2022) · Molecules · doi:10.3390/molecules27207058 · Cited by 65 · see citing works

Enantiospecific photoresponse of sterically hindered diarylethenes for chiroptical switches and photomemories

Li, W., Li, X., Xie, Y., Wu, Y., Li, M., Wu, X., Zhu, W., & Tian, H. (2015) · Scientific Reports · doi:10.1038/srep09186 · Cited by 65 · see citing works

Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature

Murteira, S., Ghezaiel, Z., Karray, S., & Lamure, M. P. (2013) · Journal of Market Access & Health Policy · doi:10.3402/jmahp.v1i0.21131 · Cited by 65 · see citing works

Classics in Chemical Neuroscience: Methylphenidate

Wenthur, C. J. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00199 · Cited by 65 · see citing works

Continuous Preferential Crystallization of Chiral Molecules in Single and Coupled Mixed-Suspension Mixed-Product-Removal Crystallizers

Galan, K., Eicke, M. J., Elsner, M. P., Lorenz, H., & Seidel‐Morgenstern, A. (2015) · Crystal Growth & Design · doi:10.1021/cg501854g · Cited by 63 · see citing works

Solid-state characterization of optically pure (+)Dihydromyricetin extracted from Ampelopsis grossedentata leaves

Wang, C., Xiong, W., Perumalla, S. R., Fang, J., & Sun, C. C. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.07.018 · Cited by 62 · see citing works

The strategy of enantiomer patents of drugs

Agranat, I., & Wainschtein, S. R. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.007 · Cited by 61 · see citing works

Fenfluramine repurposing from weight loss to epilepsy: What we do and do not know

Odi, R., Invernizzi, R. W., Gallily, T., Bialer, M., & Perucca, E. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107866 · Cited by 60 · see citing works

Recent Advances on Catalytic Asymmetric Synthesis of Molecules Bearing a Fluorine-Containing Stereogenic Carbon Center (2015–2024)

Kalita, S. J., Qi, J., Xiao, L., Saha, D., Huang, Y., & Shibata, N. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00177 · Cited by 60 · see citing works

Conformational Studies and Atropisomerism Kinetics of the ALK Clinical Candidate Lorlatinib (PF‐06463922) and Desmethyl Congeners

Elleraas, J., Ewanicki, J., Johnson, T. W., Sach, N. W., Collins, M. R., & Richardson, P. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201509240 · Cited by 59 · see citing works

Homo- and heterochiral dimers (PHFX)2, X = Cl, CN, CH3, NC: To what extent do they differ?

Bene, J. E. D., Sánchez‐Sanz, G., Alkorta, I., & Elguero, J. (2012) · Chemical Physics Letters · doi:10.1016/j.cplett.2012.04.039 · Cited by 57 · see citing works

Chiral switch:single enantiomer drugs from racemates

Zhong, B. (2008) · Chemical Reagents

Drug chirality & its clinical significance evident, future for the development/separation of single enantiomer drug from racemates- The chiral switch.

Sumithira, G., Sujatha, M. L., & Siva, M. (2013) · Cited by 3 · see citing works

CHIRAL SWITCH- AN EMERGING STRATEGY IN THERAPEUTICS

Sharma, S., Sharma, A. K., Gupta, A. K., Dahiya, N., & Brashier, D. B. S. (2014) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v4i2.794 · Cited by 3 · see citing works

The strategy of chiral switches in drug discovery

D’Acquarica, I. (2022) · IRIS Research product catalog (Sapienza University of Rome)

[Chiral switch: pure enantiomers of drugs instead of racemic mixtures]. [Czech]

Valentova, J., & Hutt, A. J. (2004) · Research Portal (King's College London)